Ra Capital Management as of March 31, 2019
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 29 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 21.0 | $486M | 4.1M | 117.70 | |
| Wave Life Sciences (WVE) | 13.0 | $302M | 7.8M | 38.85 | |
| Synthorx | 8.5 | $198M | 9.7M | 20.37 | |
| Zogenix | 5.7 | $131M | 2.4M | 55.01 | |
| Ra Pharmaceuticals | 4.7 | $109M | 4.9M | 22.40 | |
| Inflarx Nv (IFRX) | 4.6 | $106M | 2.8M | 37.79 | |
| Orchard Therapeutics Plc ads | 3.9 | $91M | 5.1M | 17.88 | |
| Eidos Therapeutics | 3.9 | $91M | 2.2M | 42.11 | |
| Myovant Sciences | 3.6 | $85M | 3.5M | 23.87 | |
| BioCryst Pharmaceuticals (BCRX) | 3.0 | $71M | 8.7M | 8.14 | |
| Tg Therapeutics (TGTX) | 2.8 | $66M | 8.2M | 8.04 | |
| Sage Therapeutics (SAGE) | 2.6 | $61M | 384k | 159.05 | |
| Rhythm Pharmaceuticals (RYTM) | 2.2 | $52M | 1.9M | 27.41 | |
| Axsome Therapeutics (AXSM) | 2.0 | $47M | 3.3M | 14.23 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.8 | $43M | 1.9M | 22.76 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $41M | 1.4M | 28.62 | |
| Kala Pharmaceuticals | 1.6 | $38M | 4.5M | 8.27 | |
| Momenta Pharmaceuticals | 1.6 | $37M | 2.6M | 14.53 | |
| Dicerna Pharmaceuticals | 1.6 | $36M | 2.5M | 14.65 | |
| Eiger Biopharmaceuticals | 1.5 | $34M | 2.4M | 13.98 | |
| Precision Biosciences Ord | 1.4 | $33M | 1.8M | 17.95 | |
| Arvinas Ord (ARVN) | 1.4 | $32M | 2.1M | 14.76 | |
| Moderna (MRNA) | 1.3 | $31M | 1.5M | 20.35 | |
| Iovance Biotherapeutics (IOVA) | 1.1 | $25M | 2.6M | 9.51 | |
| Solid Biosciences | 1.1 | $25M | 2.7M | 9.20 | |
| Alector (ALEC) | 0.8 | $19M | 1.0M | 18.72 | |
| Shockwave Med (SWAV) | 0.7 | $17M | 496k | 33.47 | |
| Scpharmaceuticals (SCPH) | 0.4 | $8.6M | 2.9M | 3.00 | |
| G1 Therapeutics (GTHX) | 0.3 | $6.0M | 363k | 16.60 |
